Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MORN
MORN logo

MORN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Morningstar Inc (MORN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
184.660
1 Day change
1.74%
52 Week Range
316.710
Analysis Updated At
2026/06/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Morningstar is not a clear buy right now for a Beginner investor with a long-term focus and $50,000-$100,000 to deploy. The business fundamentals look solid, and the latest quarter showed healthy revenue growth plus aggressive buybacks, but the current setup does not offer a strong enough entry for an impatient buyer. Technicals are only neutral, options sentiment is mixed, insider activity is notably negative, and recent congress trading shows selling rather than buying. My direct view: hold and wait for a better entry rather than buying immediately.

Technical Analysis

MORN is trading pre-market at 183.91, just above pivot support at 182.521. RSI_6 is 55.0, which is neutral, and MACD histogram is positive at 1.156 but contracting, suggesting momentum is not strongly accelerating. Moving averages are converging, which usually points to a sideways-to-cautious trend rather than a strong breakout. Key levels to watch are resistance at 193.147 (R1) and support at 171.896 (S1). Short-term pattern data suggests limited upside in the very near term, with only a 30% chance of a 2% move next day, 2.65% in the next week, and 10.06% in the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is close to balanced but slightly cautious. The open interest put-call ratio of 0.94 is near neutral, while option volume put-call ratio of 0.0 reflects very limited bearish hedging activity in today's flow. Implied volatility is elevated at 42.56 with IV percentile at 91.27, meaning options are relatively expensive compared with its recent history. That supports a cautious interpretation rather than a strong bullish signal. There is no AI Stock Picker or SwingMax buy signal today.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • ["Q1 2026 revenue grew 10.8% year over year to $644.8 million.", "Credit segment revenue rose 38.4% to $101 million, showing strong segment momentum.", "The company continued an active buyback program, repurchasing shares in 2025 and Q1 2026.", "Hedge funds have been buying aggressively, with buying amount up 395.58% last quarter.", "Forward P/E around 17 suggests the stock is not excessively priced versus earnings."]

Neutral/Negative Catalysts

  • ["Insiders are selling heavily, with selling up 1983.31% over the last month.", "Congress trading data shows 2 recent sales and 0 purchases, indicating a bearish positioning by lawmakers.", "AI Stock Picker gave no signal today and SwingMax also shows no recent buy setup.", "MACD momentum is positive but contracting, reducing confidence in immediate upside.", "Recent news around SpaceX valuation and IPO hype is not a direct positive catalyst for MORN itself.", "Options volatility is high, making the current entry less attractive for a beginner seeking stability."]

Financial Performance

Latest quarter: Q1 2026. Morningstar reported revenue of $644.8 million, up 10.8% year over year, which indicates steady top-line growth. The credit segment was a standout, with revenue rising 38.4% to $101 million. The company also continued substantial share repurchases, supporting per-share value creation. Overall, the latest quarter shows healthy growth trends and shareholder-friendly capital allocation.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst tone appears constructive but not euphoric, with valuation commentary pointing to a forward P/E of about 17 and support from revenue growth and buybacks. The broader Wall Street view is mixed-to-positive: the pros are stable growth, strong credit segment momentum, and buybacks; the cons are insider selling, a lack of near-term technical strength, and no fresh bullish catalyst from the provided news or signals. Net view: cautiously positive long term, but not an urgent buy today.

Wall Street analysts forecast MORN stock price to rise
2 Analyst Rating
Wall Street analysts forecast MORN stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 181.510
sliders
Low
250
Averages
285
High
320
Current: 181.510
sliders
Low
250
Averages
285
High
320
BMO Capital
Outperform
to
NULL
downgrade
$257 -> $193
AI Analysis
2026-02-17
Reason
BMO Capital
Price Target
$257 -> $193
AI Analysis
2026-02-17
downgrade
Outperform
to
NULL
Reason
BMO Capital lowered the firm's price target on Morningstar to $193 from $257 and keeps an Outperform rating on the shares. The company's Q4 results topped estimates, but Morningstar Direct Platform and PitchBook growth decelerated and the management noted some corrective actions in PitchBook given several headwinds the company is facing around competition, sales cycles, and AI strategy, the analyst tells investors in a research note.
UBS
Buy
to
Buy
downgrade
$320 -> $280
2026-02-13
Reason
UBS
Price Target
$320 -> $280
2026-02-13
downgrade
Buy
to
Buy
Reason
UBS lowered the firm's price target on Morningstar to $280 from $320 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MORN
Unlock Now

People Also Watch